RDX
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Redox Limited is a distributor of chemicals, ingredients, and raw materials. The company sources products from overseas manufacturers and sells them to businesses that use these inputs in manufacturing and production processes. Its operations include sourcing, regulatory management, warehousing, value-add services such as mixing, blending, formulating, filling, packaging, and laboratory testing, as well as logistics coordination and delivery. Redox serves customers across approximately 170 industries, including food and beverage, personal care, human health, animal health and nutrition, crop production, detergents, water treatment, surface coatings, plastics, rubber, mining, oil and gas, metals, building and construction, textiles, leather, and lubricants. The company operates in Australia, New Zealand, Malaysia, the United Kingdom, Mexico, and the United States. Redox utilizes an integrated Enterprise Resource Planning and Customer Relationship Management platform named Redebiz to manage its business operations. The company was founded in 1965 as C&K Industrial Traders and was renamed Redox Chemicals Pty Ltd in 1974. Recent acquisitions include Optigen Ingredients, Element Raw Materials, Oleum, and Molekulis.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Capital Goods Homepage redox.com
Sector Industrials IR page redox.com/investor-centre
Tags
chemical distribution, ingredient supply, raw materials, food and beverage, personal care, animal nutrition, crop protection, water treatment, plastics, rubber, mining chemicals, surface coatings, Redebiz, Optigen Ingredients, Element Raw Materials, Oleum, Molekulis, Bribros, Deltrex
Press page redox.com/news

Metrics

Valuation  
Market cap A$ 1.838B
Market cap (USD) $ 1.23B
P/E 19.35
PEG 4.38
P/BV 3.16
P/S 1.38
P/OCF 20.93
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 16.6%
ROI 15.9%
ROIC 22.2%
Profit margin 6.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) 4.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 3.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 15
Quality score 26.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Revenue 1.33B 1.244B 1.137B 1.258B 1.082B
Net profit 91.912M 77.101M 90.236M 80.73M 88.024M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Share price 3.33 — — — —
P/OCF 19.9 — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Posted 28 Oct 2026 in Animal Nutrition

Share

Glycine is the simplest amino acid yet serves a remarkably diverse and interconnected range of physiological functions in dogs and cats. Together with arginine, it can synthesize creatine, providing energy buffering for muscle and brain.

Simultaneously, glycine is essential for collagen structure, glutathione synthesis, hepatic detoxification, neurotransmission, gastrointestinal protection, and immune modulation. These functions are not independent-they compete for the same glycine pool, meaning that inadequate dietary glycine compromises multiple systems at once.

Glycine is conditionally essential in pet food and dietary supply becomes critical under certain conditions such as growth, aging, disease, high protein feeding. When one pathway is highly effective such as creatine synthesis in a growing kitten, detoxification in a pet with liver disease, or collagen repair in in an arthritic senior dog, less glycine is available for other functions. Thus, glycine requirements are higher for dogs and cats than what would be predicted from creatine synthesis alone.

Working dogs, growing puppies and kittens, and athletic or active pets have higher glycine and arginine requirements. Conversely, when glycine is limited, creatine synthesis is compromised, leading to fatigue, muscle weakness, potentially neurological signs. Glycine is the most abundant amino acids in collagen, the primary structural protein of skin, bone, cartilage, tendons and ligaments. Without adequate glycine, collagen fibre cannot form properly, resulting in weak connective tissue, poor wound healing, joint laxity, and skin fragility.

Collagen synthesis consumes large amounts of glycine-each collagen molecule contains approximately 330 glycine residues. In a growing or senior pet, simultaneous demands for creatine and collagen can strain the glycine pool. Senior dogs and cats with osteoarthritis or skin conditions, as well as animals recovering from surgery or injury, require additional glycine for collagen repair. There are five glycine deficiency risk factors in pet food.

  1. Plant-based and pulses-heavy formulation

Pulses such as beans, peas, lentils and chicken peas provide some glycine but levels vary. Formulations relying heavily on single plant proteins may lack sufficient glycine for all competing demand.

  1. Diets low in connective tissue and skin

Glycine is abundant in collagen-rich tissues such as skin, cartilage, tendons, bone broth and gelatine. Lean muscle meat is relatively low in glycine. A diet composed of primarily of lean muscle meat without added glycine sources risk deficiency across all glycine functions.

  1. High protein, low collagen diets

High protein diets for active dogs or cats often use concentrated muscle protein such as chicken meat and fish meal. Without added collagen, gelatine, or free glycine, the arginine: glycine ratio becomes unbalanced. This limits creatine synthesis first, but if glycine is severely deficient, all other functions also suffer.

  1. NO AAFCO minimum for glycine

There is no AAFCO minimal requirements for glycine. However, functional requirements suggest approximately 0.8-1.2% for cats and 0.5-1.0% for dogs on a dry matter basis.

  1. EFSA safety limit

The European Food Safety Authority (EFSA) Panel considers glycine at up to 20 gram per kilogram (2%) in food for cats and dogs as safe, noting that high concentrations may influence food preference because glycine is slightly sweet.

In practice, usually supplementation of free glycine could ideally maintain arginine: glycine above 1.1:1 to meet the full range of glycine metabolism demand.

For growing puppies and kittens: ensure adequate glycine (1.0-1.5%) to support simultaneous creatine synthesis, collagen deposition, and heme synthesis.

For working and athletic dogs, higher glycine (1.2-1.8%) supports creatine for energy buffering and glutathione for excise-induced oxidative stress.

For senior pets, increase glycine to 1.5-2.0% to support collagen, glutathione, and detoxification.

For cats, always ensure arginine is at least 1.04-1.25% on a dry matter basis. Glycine should be 0.8-1.2% minimum, but higher 1.5-2.0% benefit senior cats or those with liver disease.

For pets with inflammatory conditions such as dermatitis, inflammatory bowl disease (IBD) and arthritis, glycine at 1.2-1.8% provides anti-inflammatory support.

A study compiled by our Redox Animal Nutritionists .

Share

Back to all News

Posted 28 Oct 2026 in Animal Nutrition

Glycine Supplementation in Pet Food: Supporting Dogs and Cats Through Every Life Stage

Glycine is the simplest amino acid yet serves a remarkably diverse and interconnected range of physiological functions in dogs and cats. Together with arginine, it can synthesize creatine, providing energy buffering for muscle and...

Glycine Supplementation in Pet Food: Supporting Dogs and Cats Through Every Life Stage

Posted 18 Oct 2026 in Announcements

Redox achieves ISO 45001 occupational health and safety accreditation

Redox has achieved national ISO 45001 certification, reinforcing our commitment to workplace health and safety requirements for independently verified management systems. ISO 45001 is the internationally recognised standard for...

Redox achieves ISO 45001 occupational health and safety accreditation

Posted 5 Oct 2026 in Announcements

Redox appointed Dow agent for DOW Latex Powders in Australia and New Zealand

Redox has been appointed Dow’s agent for DOW™ Latex Powders (DLP) in Australia and New Zealand, providing construction chemical manufacturers with a local Redox contact for the range. The appointment covers DLP redispersible polymer...

Redox appointed Dow agent for DOW Latex Powders in Australia and New Zealand

Locations

Decorative Location Map with pins on Australia, New Zealand, Malaysia, and USA

Contact Us

Careers

Footer Navigation

© 2026 Redox

To provide you with a more personalized experience, this website may place cookies on your computer. By accepting cookies you agree to this use of your data under Redox's Privacy Policy . If you reject cookies, this website will gather anonymized website activity. To control your privacy settings in Google Analytics, please see the guidance in our Privacy Policy.

To find out more about the cookies we use, how we use information collected via cookies, and how to opt out of cookies, please read Redox's Privacy Policy .

Accept Decline

Redox achieves ISO 45001 occupational health and safety accreditation Bull 1 Bear 0 Product/operations

Posted 18 Oct 2026 in Announcements

Share

Redox has achieved national ISO 45001 certification, reinforcing our commitment to workplace health and safety requirements for independently verified management systems.

ISO 45001 is the internationally recognised standard for occupational health and safety management systems. It provides a structured framework for identifying hazards, controlling workplace risks, preventing work-related injuries and illness, and continually improving safety performance.

The certification demonstrates that Redox actively manages health and safety through established processes and ongoing review. It recognises a systematic approach to protecting employees and contractors, with independent verification that our management system meets the standard’s requirements.

Redox’s ISO 45001 certified system reflects our commitment to maintaining a safe and healthy workplace through structured risk management, continuous improvement and independent certification.

Redox’s ISO 45001 certified system reflects our commitment to maintaining a safe and healthy workplace through structured risk management, continuous improvement and independent certification.

This provides greater confidence in partnering with a supplier that prioritises its people, manages risks and operates to internationally recognised standards. Effective safety management also supports reliable operations by helping reduce the risk of disruptions caused by workplace incidents.

Achieving certification marks an important milestone in Redox’s ongoing commitment to continuous improvement. As our business grows and requirements evolve, we will continue to strengthen our health and safety systems, proactively identify and manage risks, and embed safe working practices across our operations. By protecting our employees and contractors and supporting a safer, more resilient workplace, we also reinforce the consistent, dependable service our customers rely on.

Share

Back to all News

Posted 18 Oct 2026 in Announcements

Redox achieves ISO 45001 occupational health and safety accreditation

Redox has achieved national ISO 45001 certification, reinforcing our commitment to workplace health and safety requirements for independently verified management systems. ISO 45001 is the internationally recognised standard for...

Redox achieves ISO 45001 occupational health and safety accreditation

Posted 5 Oct 2026 in Announcements

Redox appointed Dow agent for DOW Latex Powders in Australia and New Zealand

Redox has been appointed Dow’s agent for DOW™ Latex Powders (DLP) in Australia and New Zealand, providing construction chemical manufacturers with a local Redox contact for the range. The appointment covers DLP redispersible polymer...

Redox appointed Dow agent for DOW Latex Powders in Australia and New Zealand

Posted 28 Sep 2026 in Careers

How Redox helps American clients navigate an uncertain world

Supplying chemicals, ingredients and raw materials during periods of stability is easy, the real test comes when supply chains are disrupted, deadlines tighten or the usual solution is no longer available. Some of Redox USA’s strongest...

How Redox helps American clients navigate an uncertain world

Locations

Decorative Location Map with pins on Australia, New Zealand, Malaysia, and USA

Contact Us

Careers

Footer Navigation

© 2026 Redox

To provide you with a more personalized experience, this website may place cookies on your computer. By accepting cookies you agree to this use of your data under Redox's Privacy Policy . If you reject cookies, this website will gather anonymized website activity. To control your privacy settings in Google Analytics, please see the guidance in our Privacy Policy.

To find out more about the cookies we use, how we use information collected via cookies, and how to opt out of cookies, please read Redox's Privacy Policy .

Accept Decline

Appendix 3Y - Raimond Coneliano Bull 0 Bear 0 Routine

Prompts

Redox Limited (ticker RDX), listed in Australia.

ETFs Holding Redox Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.02% 32,351 $ 71.81K Nov 16, 2026
DFSI 0.00% 12,736 $ 29.836K Nov 12, 2026
DFIS 0.00% 54,984 $ 128.808K Nov 12, 2026
AVDE 0.00% 109,947 $ 244.051K Nov 16, 2026
AVDV 0.00% 54,534 $ 121.05K Nov 16, 2026